You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

362 Items

Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline

Document Status: In-Review
ID: 3-15
Version: 2

Sep 2014

Systemic Therapy in the Curative Treatment of Head and Neck Squamous Cell Cancer

Document Status: Current
ID: 5-11
Version: 2

Jan 2022

Systemic therapy of denosumab in altering surgical outcomes in patients with giant cell tumour of bone

Document Status: Current
ID: ES 11-13

Feb 2021

Systemic Treatment Computerized Prescriber Order Entry (ST CPOE): Best Practice Guideline for Intravenous and Oral Chemotherapy

Document Status: Current
ID: GL-C50-26

Feb 2016

Systemic Treatment Emergency Preparedness Guidance Document

Document Status: Current

Updated

Aug 2025

Systemic Treatment of Acute Myeloid Leukemia (AML)

Document Status: In-Review
ID: 12-9

Jan 2016

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Mar 2025

Target Wait Times for Cancer Surgery in Ontario

Document Status: Current
ID: GL-C50-03

Apr 2006

Temozolomide for the Treatment of Metastatic Melanoma

Document Status: Archived
ID: 8-4

Sep 2011

Temozolomide Monotherapy for the Treatment of Patients with Glioblastoma that has Relapsed or Progressed Following Prior Therapy

Document Status: Archived
ID: CED 20

Mar 2011

Thalidomide in Multiple Myeloma

Document Status: Archived
ID: 6-21

Jan 2010

The Continued Use of Trastuzumab Beyond Disease Progression in Patients with Metastatic Breast Cancer

Document Status: Archived
ID: CED 13

Jun 2009